查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
色胺 API 全球市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按等级、按原料、按应用、按地区
市场调查报告书
商品编码
1397319

色胺 API 全球市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按等级、按原料、按应用、按地区

Tryptamines API Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 289 Pages | 商品交期: 2-5个工作天内

价格
简介目录

全球色胺 API（活性药物成分）市场规模经历了显着增长，预计 2024 年收入将达到 6.3 亿美元。 该市场持续快速扩张，预计到2031年底估值将达到1.65兆美元。

色胺原料药市场是由多种因素驱动的，包括偏头痛疾病盛行率的上升、色胺潜在的抗癌作用，以及色胺在神经和精神疾病治疗中的探索。我正在实现它。 对特种药物的需求促进了色胺 API 市场的成长，尤其是在北美，因为色胺 API 越来越多地用于治疗偏头痛和其他神经系统疾病。

偏头痛是最常见的神经系统疾病之一，每年影响超过 10 亿人。 偏头痛发展的复杂性，加上各种社会和生物风险因素，刺激了对有效治疗的需求，推动了色胺原料药市场的发展。 由于认识到其治疗潜力，对包括色胺迷幻剂在内的精神活性化学物质的神经效应的研究增加。 色胺用于治疗各种神经和精神疾病的探索预计将推动市场成长。

本报告调查了全球色胺原料药市场，并提供了市场概况，包括按等级、原材料、应用、地区划分的趋势以及进入市场的公司的竞争趋势。

目录

第 1 章执行摘要

第二章市场概述

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影响分析
  • 乌克兰和俄罗斯之间衝突的影响
  • 经济概况
  • 杵分析

第三章2018-2023年生产与贸易统计

第 4 章价格分析，2018-2023

第 5 章2018-2031 年全球色胺 API 市场展望

  • 2018-2031 年全球色胺 API 市场前景（依等级、价值（十亿美元）、数量（公斤））
  • 2018-2031 年全球色胺 API 市场前景（依原料、价值（十亿美元）、数量（公斤））
  • 2018-2031 年全球色胺 API 市场前景（按应用分类）、价值（十亿美元）、数量（公斤）
  • 2018-2031 年全球色胺 API 市场展望，以地区、价值（美元）、数量（公斤）

第 6 章北美色胺 API 市场展望，2018-2031

第 7 章欧洲色胺 API 市场前景，2018-2031

第 8 章亚太地区色胺 API 市场展望，2018-2031

第 9 章拉丁美洲色胺 API 市场展望，2018-2031

第10章中东与非洲色胺原料药市场前景，2018-2031

第十一章竞争态势

  • 最终用户和原料的热图
  • 按製造商和原料划分的热图
  • 2023 年公司市占率分析
  • 竞争力仪表板
  • 公司简介
    • Merck
    • Avra Synthesis Private Limited
    • Spectrum Chemical
    • Cayman Chemical Company (Matreya)
    • Tokyo Chemical Industry Co. Ltd.
    • Santa Cruz Biotechnology, Inc.
    • LGC Standards
    • Avra Synthesis Private Limited
    • SimSon Pharma Limited
    • Glentham Life

第12章附录

简介目录

The Global Tryptamines API (Active Pharmaceutical Ingredient) Market has witnessed substantial growth, recording revenue of US$ 630 million in 2024. The market is projected to continue its rapid expansion, aiming to reach a valuation of US$ 1650 billion by the end of 2031, according to a recent report released by Fairfield Market Research.

Key Market Highlights:

  • Tryptamines and Their Significance: Tryptamines are monoamine alkaloids found in mammals, fungi, and plants, with structural similarities to the amino acid tryptophan. They serve as the foundation for various biologically active substances, including psychedelic drugs and neurotransmitters.
  • Market Growth Drivers: The market for Tryptamines APIs is experiencing growth due to several factors, including the rising prevalence of migraine disorders, the potential anti-cancer effects of tryptamine, and the exploration of tryptamines for therapeutic use in neurological and psychiatric conditions.
  • Demand for Specialized Pharmaceuticals: The need for specialized pharmaceuticals, particularly in North America, has contributed to the growth of the Tryptamines API market, as these APIs are increasingly utilized in the treatment of migraine and other neurological conditions.

Factors Fueling Market Growth:

  • Prevalence of Migraine Disorders: Migraine is one of the most common neurological disorders, affecting over one billion people annually. The complexity of migraine development, along with various social and biological risk factors, has led to an increased demand for effective treatments, driving the market for Tryptamines APIs.
  • Psychoactive Chemicals and Therapeutic Potential: Research into the neurological effects of psychoactive chemicals, including tryptamine psychedelics, has grown due to their perceived therapeutic potential. The exploration of tryptamines for treating various neurological and psychiatric conditions is expected to fuel market growth.

Challenges Affecting Market Growth:

  • High Capital Investment: The manufacturing of Tryptamines APIs involves significant capital investment due to various factors, including infrastructure, equipment, and quality standards. These high capital requirements may hinder market growth.

Key Market Dynamics:

  • United States Market Surge: North America, particularly the United States, is expected to dominate the Tryptamines API market due to the region's increasing demand for specialized pharmaceuticals and the high prevalence of migraine disorders.
  • Germany's Lucrative Market: Germany offers numerous advantages for Tryptamines API manufacturers, including investments in R&D projects and the presence of significant regional market participants.
  • China's Growing Market: China is becoming a prominent market for Tryptamines APIs, with Chinese API producers obtaining globally recognized Good Manufacturing Practice (GMP) accreditation.

Highly Sought-after API Grade: GMP-grade Tryptamines APIs, produced in compliance with established quality standards for clinical use, are in high demand.

Preferred Source of Tryptamines APIs: Synthetic chemical APIs, known as small molecules, are widely used in the pharmaceutical industry. They include medications like sumatriptan, ondansetron, and alosetron.

Competitive Landscape:

Major market players are focusing on expansion strategies to tap into potential markets, emphasizing the mass production of GMP-compliant products with market potential in underdeveloped regions.

Key Companies in the Market:

  • Merck
  • Spectrum Chemical
  • LGC Standards
  • Cayman Chemical Company (Matreya)
  • Psygen
  • Biosynth
  • Clearsynth Labs
  • Glentham Life
  • Pharmaffiliates Analytics and Synthetics P. Ltd.
  • Santa Cruz Biotechnology, Inc.
  • SimSon Pharma Limited
  • Otto Chemie Pvt. Ltd
  • Tokyo Chemical Industry Co. Ltd.
  • Avra Synthesis Private Limited

Market Segmentation

Grade:

  • GMP Grade
  • Non-GMP Grade

Source:

  • Natural
  • Synthetic
  • Bio-Synthetic

Application:

  • Clinical Use
  • Research Use

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Tryptamines API Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

  • 3.1. Global Tryptamines API Market Production Output, by Region, Value (US$ Bn) and Volume (in Kgs), 2018 - 2023
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

  • 4.1. Global Average Price Analysis, by Grade/ Material, US$ Per Unit, 2018 - 2023
  • 4.2. Prominent Factor Affecting Peripheral Stent Implants Prices
  • 4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Tryptamines API Market Outlook, 2018 - 2031

  • 5.1. Global Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. GMP Grade
      • 5.1.1.2. Non-GMP Grade
  • 5.2. Global Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Natural
      • 5.2.1.2. Synthetic
      • 5.2.1.3. Bio-Synthetic
  • 5.3. Global Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Clinical Use
      • 5.3.1.2. Research Use
  • 5.4. Global Tryptamines API Market Outlook, by Region, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. North America
      • 5.4.1.2. Europe
      • 5.4.1.3. Asia Pacific
      • 5.4.1.4. Latin America
      • 5.4.1.5. Middle East & Africa

6. North America Tryptamines API Market Outlook, 2018 - 2031

  • 6.1. North America Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. GMP Grade
      • 6.1.1.2. Non-GMP Grade
  • 6.2. North America Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Natural
      • 6.2.1.2. Synthetic
      • 6.2.1.3. Bio-Synthetic
  • 6.3. North America Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Clinical Use
      • 6.3.1.2. Research Use
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. North America Tryptamines API Market Outlook, by Country, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. U.S. Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 6.4.1.2. U.S. Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 6.4.1.3. U.S. Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 6.4.1.4. Canada Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 6.4.1.5. Canada Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 6.4.1.6. Canada Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Tryptamines API Market Outlook, 2018 - 2031

  • 7.1. Europe Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. GMP Grade
      • 7.1.1.2. Non-GMP Grade
  • 7.2. Europe Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Natural
      • 7.2.1.2. Synthetic
      • 7.2.1.3. Bio-Synthetic
  • 7.3. Europe Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Clinical Use
      • 7.3.1.2. Research Use
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Europe Tryptamines API Market Outlook, by Country, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Germany Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.2. Germany Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.3. Germany Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.4. U.K. Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.5. U.K. Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.6. U.K. Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.7. France Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.8. France Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.9. France Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.10. Italy Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.11. Italy Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.12. Italy Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.13. Turkey Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.14. Turkey Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.15. Turkey Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.16. Russia Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.17. Russia Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.18. Russia Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.19. Rest of Europe Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.20. Rest of Europe Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 7.4.1.21. Rest of Europe Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Tryptamines API Market Outlook, 2018 - 2031

  • 8.1. Asia Pacific Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. GMP Grade
      • 8.1.1.2. Non-GMP Grade
  • 8.2. Asia Pacific Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Natural
      • 8.2.1.2. Synthetic
      • 8.2.1.3. Bio-Synthetic
  • 8.3. Asia Pacific Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Clinical Use
      • 8.3.1.2. Research Use
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Asia Pacific Tryptamines API Market Outlook, by Country, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. China Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.2. China Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.3. China Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.4. Japan Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.5. Japan Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.6. Japan Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.7. South Korea Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.8. South Korea Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.9. South Korea Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.10. India Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.11. India Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.12. India Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.13. Southeast Asia Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.14. Southeast Asia Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.15. Southeast Asia Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.16. Rest of Asia Pacific Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.17. Rest of Asia Pacific Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 8.4.1.18. Rest of Asia Pacific Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Tryptamines API Market Outlook, 2018 - 2031

  • 9.1. Latin America Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. GMP Grade
      • 9.1.1.2. Non-GMP Grade
  • 9.2. Latin America Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.2.1.1. Natural
    • 9.2.1.2. Synthetic
    • 9.2.1.3. Bio-Synthetic
  • 9.3. Latin America Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Clinical Use
      • 9.3.1.2. Research Use
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis
  • 9.4. Latin America Tryptamines API Market Outlook, by Country, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. Brazil Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.2. Brazil Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.3. Brazil Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.4. Mexico Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.5. Mexico Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.6. Mexico Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.7. Argentina Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.8. Argentina Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.9. Argentina Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.10. Rest of Latin America Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.11. Rest of Latin America Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 9.4.1.12. Rest of Latin America Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Tryptamines API Market Outlook, 2018 - 2031

  • 10.1. Middle East & Africa Tryptamines API Market Outlook, by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.1.1. Key Highlights
      • 10.1.1.1. GMP Grade
      • 10.1.1.2. Non-GMP Grade
  • 10.2. Middle East & Africa Tryptamines API Market Outlook, by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.2.1. Key Highlights
      • 10.2.1.1. Natural
      • 10.2.1.2. Synthetic
      • 10.2.1.3. Bio-Synthetic
  • 10.3. Middle East & Africa Tryptamines API Market Outlook, by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.3.1. Key Highlights
      • 10.3.1.1. Clinical Use
      • 10.3.1.2. Research Use
    • 10.3.2. BPS Analysis/Market Attractiveness Analysis
  • 10.4. Middle East & Africa Tryptamines API Market Outlook, by Country, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.4.1. Key Highlights
      • 10.4.1.1. GCC Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.2. GCC Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.3. GCC Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.4. South Africa Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.5. South Africa Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.6. South Africa Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.7. Egypt Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.8. Egypt Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.9. Egypt Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.10. Nigeria Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.11. Nigeria Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.12. Nigeria Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.13. Rest of Middle East & Africa Tryptamines API Market by Grade, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.14. Rest of Middle East & Africa Tryptamines API Market by Source, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
      • 10.4.1.15. Rest of Middle East & Africa Tryptamines API Market by Application, Value (US$ Bn) and Volume (in Kgs), 2018 - 2031
    • 10.4.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

  • 11.1. By End User vs by Source Heat map
  • 11.2. Manufacturer vs by Source Heatmap
  • 11.3. Company Market Share Analysis, 2023
  • 11.4. Competitive Dashboard
  • 11.5. Company Profiles
    • 11.5.1. Merck
      • 11.5.1.1. Company Overview
      • 11.5.1.2. Product Portfolio
      • 11.5.1.3. Financial Overview
      • 11.5.1.4. Business Strategies and Development
    • 11.5.2. Avra Synthesis Private Limited
      • 11.5.2.1. Company Overview
      • 11.5.2.2. Product Portfolio
      • 11.5.2.3. Financial Overview
      • 11.5.2.4. Business Strategies and Development
    • 11.5.3. Spectrum Chemical
      • 11.5.3.1. Company Overview
      • 11.5.3.2. Product Portfolio
      • 11.5.3.3. Financial Overview
      • 11.5.3.4. Business Strategies and Development
    • 11.5.4. Cayman Chemical Company (Matreya)
      • 11.5.4.1. Company Overview
      • 11.5.4.2. Product Portfolio
      • 11.5.4.3. Financial Overview
      • 11.5.4.4. Business Strategies and Development
    • 11.5.5. Tokyo Chemical Industry Co. Ltd.
      • 11.5.5.1. Company Overview
      • 11.5.5.2. Product Portfolio
      • 11.5.5.3. Financial Overview
      • 11.5.5.4. Business Strategies and Development
    • 11.5.6. Santa Cruz Biotechnology, Inc.
      • 11.5.6.1. Company Overview
      • 11.5.6.2. Product Portfolio
      • 11.5.6.3. Financial Overview
      • 11.5.6.4. Business Strategies and Development
    • 11.5.7. LGC Standards
      • 11.5.7.1. Company Overview
      • 11.5.7.2. Product Portfolio
      • 11.5.7.3. Financial Overview
      • 11.5.7.4. Business Strategies and Development
    • 11.5.8. Avra Synthesis Private Limited
      • 11.5.8.1. Company Overview
      • 11.5.8.2. Product Portfolio
      • 11.5.8.3. Financial Overview
      • 11.5.8.4. Business Strategies and Development
    • 11.5.9. SimSon Pharma Limited
      • 11.5.9.1. Company Overview
      • 11.5.9.2. Product Portfolio
      • 11.5.9.3. Financial Overview
      • 11.5.9.4. Business Strategies and Development
    • 11.5.10. Glentham Life
      • 11.5.10.1. Company Overview
      • 11.5.10.2. Product Portfolio
      • 11.5.10.3. Financial Overview
      • 11.5.10.4. Business Strategies and Development

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms and Abbreviations